Core Facilities & Units

Core Facilities & Units

We offer equipment and expertise

Our core facilities and units are used for research & development by DTU departments and hospitals, and for commercial diagnostic testing in daily operations.

Development projects & daily operation

We have liquid handlers as:

  • QIAgility
  • Biomek 4000
  • Biomek i5
  • Biomek NXP
  • Biomek i7
  • TECAN. 

We have the expertise to:

  • scale up with high sample volume and many data points/assays per samle e.g. research projects, monitoring groups of patients at regular intervals for multiple biomarkers pathogens etc. 

Read more.

Development projects & daily operation

For RNA/DNA purification we have:

  • QIAcubes
  • QIACCube HT
  • Biomek i7
  • QiaSymphony
  • BasePurifier. 

For PCR we have:

  • Biorad T-100 PCR
  • PCR, Rotorgenes
  • CFX Opus 96 Real Time PCR
  • Biomark Fluidigm + controllers. 

We have expertise to:

  • develop singleplex and multiplex real-time polymerase chain reaction ((RT)-qPCR) tests that can be applied in diagnostics and research.

Read more.

Development projects & daily operation

For assay optimizations we use a Biocore X100 instrument that can mesure binding characteristics of ligands (e.g. antibodies and aptamers) and analytes. Binding characteristics include determination of affinity, binding kinetics and concentration of the ligand or analyte. 

Read more.

Development projects & daily operation

Our serology platforms are:

 

Production & design

The LFA is a commonly used paper-based point-of-care test method for rapid detection of analytes in biological samples such as blood or saliva. The LFA is a simple, cheap and practical detection method that does not require laboratory facilities. The results are displayed within 5-30 minutes.

Read more.

Production & design

We have the facilities and expertise to generate oligonucleotide aptamers that can be used instead of antibodies as detection probes for specific and sensitive detection of analytes.

Read more.

Complement-based immunotherapeutics (CBI)

Our complement platform (CfD-CP) provides an array of complement analyses that can serve as R&D tools for drug and immunotherapy development or as diagnostic reagents.

CfD-CP can provide a broad and integrated portfolio of laboratory services for complement research, analysis, diagnostics and therapeutics.

Type of complement analysis:

  • Complement biomarker analysis
  • Pentraxin biomarker analysis
  • Opsonin binding and its function test
  • Complement activity test
  • Complement effector function test
  • Complement autoantibody test
  • Complement safety and biocompatibility test
  • Complement modification of ADCC and CDC efficacy
  • Complement modification of nanomaterial efficacy 

Complement analysis technologies:

Further questions?

Please get in touch! Also if you didn't find what you where looking for.

Contact

Helene Larsen

Helene Larsen Head of Center - Center for Diagnostics Mobile: +45 42440166